20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T16367 | NVS-PAK1-1 | PAK | |
NVS-PAK1-1 is an effective and selective allosteric PAK1 inhibitor (IC50: 5 nM). | |||
T35928 | NVS-PAK1-C | NVS-PAK1-C | |
NVS-PAK1-1 is a potent allosteric inhibitor of PAK1 with an IC 50 of 5 nM for dephosphorylated PAK1 and 6 nM for phosphorylated PAK1 as assessed. Inhibition is ATP-competitive, most likely due to indirect competition due... | |||
T41166 | NVS PAK1 C | ||
NVS PAK1 C is a negative control of NVS PAK1 1, a potent and selective PAK1 inhibitor. | |||
T63031 | PAK1-IN-1 | ||
PAK1-IN-1 is a selective and potent inhibitor of PAK1 (IC50: 9.8 nM). PAK1-IN-1 inhibits PAK1-associated tumour cell migration and invasion in a dose-dependent manner. | |||
T2427 | EHop-016 | EHop 016 | Rho , Ras |
EHop-016 is a specific Rac GTPase inhibitor with IC50 of 1.1 μM for Rac1 in MDA-MB-231 and MDA-MB-435 cells, equally effective inhibition for Rac3. | |||
T6839 | FRAX1036 | PAK | |
FRAX-1036 is a effective and selective PAK1 inhibitor. | |||
T6546 | IPA-3 | IPA3,IPA 3 | PAK |
IPA-3 is a selective non-ATP competitive Pak1 inhibitor with IC50 of 2.5 μM, no inhibition to group II PAKs (PAKs 4-6). | |||
T11342L | G-5555 | PAK | |
G-5555 is a potent inhibitor of p21-activated kinase 1 (PAK1) (Kis: 3.7 nM and 11 nM for PAK1 and PAK2, respectively). | |||
T60269 | ZINC194100678 | PAK | |
ZINC194100678 is an effective PAK1 inhibitor with IC50 of 8.37μM. ZINC194100678 showed strong anti-proliferation activity, with IC50 value of 40.16μM against MDA-MB-231. | |||
T23160 | PIR 3.5 | 6,6′-Dithiodi(2-naphthol) | PAK |
PIR 3.5 (6,6′-Dithiodi(2-naphthol)) is a negative control of IPA 3 which is a Pak1 inhibitor. | |||
T6014 | FRAX597 | PAK | |
FRAX597 is an effective, ATP-competitive inhibitor of group I PAKs, and for PAK1(IC50=8 nM), PAK2(IC50=13 nM), and PAK3 (IC50=19 nM). | |||
T6840 | FRAX486 | PAK | |
FRAX486 is a potent p21-activated kinase (PAK) inhibitor with IC50 values of 14, 33, 39 and 575 nM for PAK1, PAK2, PAK3 and PAK4 respectively. | |||
T6840L | FRAX486 HCL(1232030-35-1 free base) | PAK | |
FRAX486 HCL is a potent p21-activated kinase (PAK) inhibitor with IC50 values of 14, 33, 39 and 575 nM for PAK1, PAK2, PAK3 and PAK4 respectively. | |||
T26704 | AZ13705339 | AZ-13705339,AZ 13705339 | PAK |
AZ13705339 is an effective inhibitor of PAK1 with an IC50 of 0.33 nM and a Kd of 0.28 nM. AZ13705339 binds PAK2 with a Kd of 0.32 nM. AZ13705339 can be used in studies about cancers. | |||
T25125 | AZA197 | AZA 197,AZA-197 | CDK |
AZA197 (AZA-197) is a selective Cdc42 inhibitor. It acts by inhibiting primary colon cancer growth and prolonging survival in a preclinical mouse xenograft model by downregulation of PAK1 activity. | |||
T7939 | Fingolimod | FTY-720A,FTY-720 | S1P Receptor , PAK , LPL Receptor |
Fingolimod (FTY-720A) is an antagonist of sphingosine 1-phosphate (S1P) (IC50 of 0.033 nM in K562 and NK cells). | |||
T0646 | 5-Aminosalicylic Acid | Mesalazine,5-ASA,Mesalamine | NF-κB , Lipoxygenase , COX , Glutathione Peroxidase , Endogenous Metabolite , PAK , PPAR |
5-Aminosalicylic Acid (5-ASA) is an anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. | |||
T63063 | ZMF-10 | ||
ZMF-10 is a potent inhibitor of PAK1, and can act on PAK1 (IC50:174 nM), PAK2 (IC50:1.038 μM) and PAK3 (IC50:1.372 μM). ZMF-10 inhibited PAK1 activity and affected Pak1-regulated apoptosis, endoplasmic reticulum stress a... | |||
T72321 | AZ13705339 hemihydrate | ||
AZ13705339 hemihydrate is a hemihydrate form of AZ13705339, exhibiting high potency and selectivity as a PAK1 inhibitor, demonstrating IC50 values of 0.33 nM for PAK1 and 59 nM for pPAK1. It also shows strong binding aff... | |||
T69243 | AK963 | ||
AK963, also known as 40708899, is a potent PAK1 (p21-activated kinase 1) inhibitor, which suppresses the proliferation of human gastric cancer cells significantly by downregulation of PAK1-NFκB-CyclinB1 pathway. |